Use of interferon alpha-2b and prednisolone in the treatment of severe intractable diarrhea in a child with systemic mastocytosis

Pediatrics International

Volumn 45, Issue 6, 2003, Pages 751-754

  Çaksen, Hüseyin ^a,b   Odabas, Dursun ^a   Öner, Ahmet Faik ^a   Cesur, Yasar ^a   Arslan, Şükrü ^a   Akbayram, Sinan ^a   Yuca, Sevil Ari ^a   Erol, Mehmet ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Interferon 2b; Intractable diarrhea; Prednisolone; Systemic mastocytosis

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2B INTERFERON; AMYLASE; ANTIBIOTIC AGENT; CALCITRIOL; CALCIUM; CEFTRIAXONE; HYDROXYZINE; LOPERAMIDE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; PROTEINASE; RANITIDINE; TRIACYLGLYCEROL LIPASE; VANCOMYCIN; VITAMIN D; VITAMIN K GROUP; ZINC SULFATE;

ANAMNESIS; ARTICLE; BACTERIAL INFECTION; CARDIOPULMONARY ARREST; CASE REPORT; CLINICAL FEATURE; CLONIC SEIZURE; DEHYDRATION; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; FAMILY HISTORY; HUMAN; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LABORATORY TEST; MALE; METABOLIC ACIDOSIS; OSTEOPOROSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SYMPTOM; SYSTEMIC MASTOCYTOSIS; TREATMENT OUTCOME; VISUAL HALLUCINATION; WEIGHT GAIN;

CHILD; DIARRHEA; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; INTERFERON ALFA-2B; MALE; MASTOCYTOSIS, SYSTEMIC; PREDNISOLONE;

EID: 1642521729     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2003.01815.x     Document Type: Article

References (15)

1. Pari F, Zamagni MD, Carnevali C et al. Systemic mastocytosis. A review of current diagnostic and therapeutic approaches. Recenti. Prog. Med. 1999; 90: 169-72 (in Italian).
2. Hubner C, Wedding U, Strater J, Limberg B, Stremmel W. Clinically stable systemic mastocytosis with interferon alpha-2b therapy. J. Intern. Med. 1997; 241: 529-33.
3. Debeuckelaere S, Schoors DF, Van Avermaet S, Roosens B, Devis G. Pancreatic calcifications in a patient with systemic mastocytosis. J. Clin. Gastroenterol. 1992; 15: 83-5.
4. Tajima Y, Hamada K, Houzenn H et al. Sequential magnetic resonance features of encephalopathy induced by systemic mastocytosis. Intern. Med. 1994; 33: 23-6.
5. Guenther PP, Huebner A, Sobottka SB et al. Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. J. Pediatr. Hematol. Oncol. 2001; 23: 134-8.
6. Jost E, Michaux L, Vanden Abeele M et al. Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage. Ann. Hematol. 2001; 80: 302-7.
7. Valent P. Biology, classification and treatment of human mastocytosis. Wien. Klein. Wochenschr. 1996; 108: 385-97.
8. Schernthaner GH, Spanblochl E, Sperr WR et al. Effects of interferon-alpha-2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis. Ann. Hematol. 2000; 79: 660-66.
9. Brunel V, Tadrist Z, Cailleres S, Allegre T, Blanc AP. Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis. Presse Med. 1998; 27: 64 (in French).
10. Fonga-Djimi HS, Gottrand F, Bonnevalle M, Farriaux JP. A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent. Eur. J. Pediatr. 1995; 154: 819-21.
11. Takasaki Y, Tsukasaki K, Jubashi T, Tomonaga M, Kamihira S, Makiyama K. Systemic mastocytosis with extensive polypoid lesions in the intestines: successful treatment with interferon-alpha. Intern. Med. 1998; 37: 484-8.
12. Worobec AS, Kirshenbaum AS, Schwartz LB, Metcalfe DD. Treatment of three patients with systemic mastocytosis with Interferon alpha-2b. Leuk. Lymphoma 1996; 22: 501-8.
13. Essner C, Thiefin G, Diebold MD, Pignon B, Caulet T, Zeitoun P. Lymphocytic ascites revealing systemic mastocytosis Gastroenterol. Clin. Biol. 1995; 19: 948-51 (in French).
14. Harrison BD, Ashford RA, Hatton CS. Systemic mastocytosis - a case treated with interferon alpha and radiotherapy. Clin. Laboratory Haematol. 1994; 16: 291-4.
15. Butterfield JH. Response of severe systemic mastocytosis to interferon alpha. Br. J. Dermatol. 1998; 138: 489-95.